ATE314465T1 - Verfahren zum screening von hochaktiven proteasen und hemmstoffen - Google Patents

Verfahren zum screening von hochaktiven proteasen und hemmstoffen

Info

Publication number
ATE314465T1
ATE314465T1 AT01960178T AT01960178T ATE314465T1 AT E314465 T1 ATE314465 T1 AT E314465T1 AT 01960178 T AT01960178 T AT 01960178T AT 01960178 T AT01960178 T AT 01960178T AT E314465 T1 ATE314465 T1 AT E314465T1
Authority
AT
Austria
Prior art keywords
protease
gene
inhibitors
highly active
active proteases
Prior art date
Application number
AT01960178T
Other languages
English (en)
Inventor
Poul Erik Pedersen
Mads Noerregaard-Madsen
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Application granted granted Critical
Publication of ATE314465T1 publication Critical patent/ATE314465T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6408Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
AT01960178T 2000-08-29 2001-07-17 Verfahren zum screening von hochaktiven proteasen und hemmstoffen ATE314465T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001273 2000-08-29
PCT/DK2001/000503 WO2002018588A1 (en) 2000-08-29 2001-07-17 Method for screening highly active proteases and inhibitors

Publications (1)

Publication Number Publication Date
ATE314465T1 true ATE314465T1 (de) 2006-01-15

Family

ID=8159678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01960178T ATE314465T1 (de) 2000-08-29 2001-07-17 Verfahren zum screening von hochaktiven proteasen und hemmstoffen

Country Status (7)

Country Link
US (1) US20040038375A1 (de)
EP (1) EP1315806B1 (de)
AT (1) ATE314465T1 (de)
AU (1) AU2001281734A1 (de)
CA (1) CA2419860A1 (de)
DE (1) DE60116337D1 (de)
WO (1) WO2002018588A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080090745A1 (en) * 2006-10-13 2008-04-17 Fox Bryan P Expression of Streptomyces subtilism inhibitor (SSI) proteins in Bacillus and Streptomyces sp.
US9403897B2 (en) 2011-10-12 2016-08-02 Sanyo Chemical Industries, Ltd. Proteinaceous protease inhibitor and protein solution and detergent composition containing it
US20170114091A1 (en) * 2014-03-28 2017-04-27 Novozymes A/S Resolubilization of protein crystals at low ph
US12019066B2 (en) * 2016-05-16 2024-06-25 Biomadison, Inc. Assay with synaptobrevin based moiety
EP3864036A1 (de) * 2018-10-10 2021-08-18 Novozymes A/S Varianten von chymotrypsin-inhibitoren und deren verwendung
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2377392A (en) * 1991-07-09 1993-02-11 Robert Balint A method for the identification of protease inhibitors
US6159688A (en) * 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
WO2000040745A1 (en) * 1999-01-08 2000-07-13 Bristol-Myers Squibb Company Prokaryotic system designed to monitor protease activity

Also Published As

Publication number Publication date
EP1315806A1 (de) 2003-06-04
AU2001281734A1 (en) 2002-03-13
CA2419860A1 (en) 2002-03-07
US20040038375A1 (en) 2004-02-26
EP1315806B1 (de) 2005-12-28
DE60116337D1 (de) 2006-02-02
WO2002018588A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
HK1081196A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
HK1090644A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
HK1098164A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
SG166001A1 (en) Methods of generating and screening for proteases with altered specificity
ATE469692T1 (de) Verbessertes verfahren zum wickeln von z- filtermedien
EP2045321A3 (de) Serinproteasen mit veränderter Empfindlichkeit gegen aktivitätsmodulierende Substanzen
ATE203545T1 (de) Substrate und inhibitoren von proteolytischen enzymen
DE60331321D1 (de) Verfahren zur wirksamen rna-interferenz in säugerzellen
AU2003272800A1 (en) Methods for identifying inhibitors of botulinum neurotoxins
ATE314465T1 (de) Verfahren zum screening von hochaktiven proteasen und hemmstoffen
EP1065213A3 (de) HCV Polymerase die für eine Krystalstruktur Analyse geeignet ist, und Verfahren zur Benutzung diesem Enzym
NO20010300D0 (no) Nye fremgangsmåter for identifisering av ligand og målbiomolekyler
EP1444362A4 (de) Hochdurchsatztranskriptome und funktionelle validierungsanalyse
HUP0300873A2 (hu) Szubsztituált oxo-butánok sztereoszelektív redukciója
DE50105206D1 (de) Verfahren zum selektieren von inhibitoren für enzyme
AU2003247599A1 (en) Methods of modulating cytokinin related processes in a plant using b3 domain proteins
Li et al. Characterising the subsite specificity of urokinase‐type plasminogen activator and tissue‐type plasminogen activator using a sequence‐defined peptide aldehyde library
ATE364078T1 (de) Verfahren zum nachweis von genen von sekretierten proteinen
WO2004026227A3 (en) A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS
DK1299532T3 (da) Forbedrende kombinatoriske biblioteker ved rekombination i gær og analysefremgangsmåder
IL166345A0 (en) Method for identifying substances
AU2003241604A1 (en) System and method for screening for protease inhibitors and proteases
ATE321877T1 (de) Fluoreszenz-verfahren zum nachweis von proteasen oder peptidasen
DE502004011298D1 (de) Verfahren zur Isolierung von Inselzellen aus Pankreasgewebe
ATE461290T1 (de) Verfahren zur identifizierung von aktivestellen- proteasinaktivatoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties